Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Kenya Treatment Course (Regimen) Code System

Active as of 2026-06-04

Raw xml | Download

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="treatment-course-codes-cs"/>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem treatment-course-codes-cs</b></p><a name="treatment-course-codes-cs"> </a><a name="hctreatment-course-codes-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/treatment-course-codes-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">AC<a name="treatment-course-codes-cs-AC"> </a></td><td>AC</td><td>Doxorubicin + Cyclophosphamide</td></tr><tr><td style="white-space:nowrap">AC-T<a name="treatment-course-codes-cs-AC-T"> </a></td><td>AC-T</td><td>Doxorubicin + Cyclophosphamide followed by Paclitaxel</td></tr><tr><td style="white-space:nowrap">AC-TH<a name="treatment-course-codes-cs-AC-TH"> </a></td><td>AC-TH</td><td>AC-T with Trastuzumab (HER2+)</td></tr><tr><td style="white-space:nowrap">CMF<a name="treatment-course-codes-cs-CMF"> </a></td><td>CMF</td><td>Cyclophosphamide + Methotrexate + 5-Fluorouracil</td></tr><tr><td style="white-space:nowrap">FAC<a name="treatment-course-codes-cs-FAC"> </a></td><td>FAC</td><td>5-Fluorouracil + Doxorubicin + Cyclophosphamide</td></tr><tr><td style="white-space:nowrap">FEC<a name="treatment-course-codes-cs-FEC"> </a></td><td>FEC</td><td>5-Fluorouracil + Epirubicin + Cyclophosphamide</td></tr><tr><td style="white-space:nowrap">TC<a name="treatment-course-codes-cs-TC"> </a></td><td>TC</td><td>Docetaxel + Cyclophosphamide</td></tr><tr><td style="white-space:nowrap">FOLFOX<a name="treatment-course-codes-cs-FOLFOX"> </a></td><td>FOLFOX</td><td>5-Fluorouracil + Leucovorin + Oxaliplatin</td></tr><tr><td style="white-space:nowrap">FOLFIRI<a name="treatment-course-codes-cs-FOLFIRI"> </a></td><td>FOLFIRI</td><td>5-Fluorouracil + Leucovorin + Irinotecan</td></tr><tr><td style="white-space:nowrap">CAPOX<a name="treatment-course-codes-cs-CAPOX"> </a></td><td>CAPOX/XELOX</td><td>Capecitabine + Oxaliplatin</td></tr><tr><td style="white-space:nowrap">BEP<a name="treatment-course-codes-cs-BEP"> </a></td><td>BEP</td><td>Bleomycin + Etoposide + Cisplatin</td></tr><tr><td style="white-space:nowrap">CHOP<a name="treatment-course-codes-cs-CHOP"> </a></td><td>CHOP</td><td>Cyclophosphamide + Doxorubicin + Vincristine + Prednisone</td></tr><tr><td style="white-space:nowrap">R-CHOP<a name="treatment-course-codes-cs-R-CHOP"> </a></td><td>R-CHOP</td><td>Rituximab + CHOP</td></tr><tr><td style="white-space:nowrap">ABVD<a name="treatment-course-codes-cs-ABVD"> </a></td><td>ABVD</td><td>Doxorubicin + Bleomycin + Vinblastine + Dacarbazine</td></tr><tr><td style="white-space:nowrap">GEM-CIS<a name="treatment-course-codes-cs-GEM-CIS"> </a></td><td>Gem-Cis</td><td>Gemcitabine + Cisplatin</td></tr><tr><td style="white-space:nowrap">GEM-CARBO<a name="treatment-course-codes-cs-GEM-CARBO"> </a></td><td>Gem-Carbo</td><td>Gemcitabine + Carboplatin</td></tr><tr><td style="white-space:nowrap">PACLITAXEL-CARBO<a name="treatment-course-codes-cs-PACLITAXEL-CARBO"> </a></td><td>Paclitaxel-Carboplatin</td><td>Paclitaxel + Carboplatin</td></tr><tr><td style="white-space:nowrap">CISPLATIN-5FU<a name="treatment-course-codes-cs-CISPLATIN-5FU"> </a></td><td>Cisplatin-5FU</td><td>Cisplatin + 5-Fluorouracil</td></tr><tr><td style="white-space:nowrap">SINGLE-CAPECITABINE<a name="treatment-course-codes-cs-SINGLE-CAPECITABINE"> </a></td><td>Single-agent Capecitabine</td><td>Capecitabine monotherapy</td></tr><tr><td style="white-space:nowrap">SINGLE-PACLITAXEL<a name="treatment-course-codes-cs-SINGLE-PACLITAXEL"> </a></td><td>Single-agent Paclitaxel</td><td>Paclitaxel monotherapy</td></tr><tr><td style="white-space:nowrap">SINGLE-GEMCITABINE<a name="treatment-course-codes-cs-SINGLE-GEMCITABINE"> </a></td><td>Single-agent Gemcitabine</td><td>Gemcitabine monotherapy</td></tr><tr><td style="white-space:nowrap">MVAC<a name="treatment-course-codes-cs-MVAC"> </a></td><td>MVAC</td><td>Methotrexate + Vinblastine + Doxorubicin + Cisplatin</td></tr><tr><td style="white-space:nowrap">OTHER<a name="treatment-course-codes-cs-OTHER"> </a></td><td>Other</td><td>Regimen not listed; specify in free text.</td></tr></table></div>
  </text>
  <url
       value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/treatment-course-codes-cs"/>
  <version value="0.1.0"/>
  <name value="TreatmentCourseCodesCS"/>
  <title value="Kenya Treatment Course (Regimen) Code System"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2026-06-04T14:49:30+00:00"/>
  <publisher value="Digital Health Agency (DHA), Kenya"/>
  <contact>
    <name value="Digital Health Agency (DHA), Kenya"/>
    <telecom>
      <system value="url"/>
      <value value="https://dha.go.ke"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="info@dha.go.ke"/>
    </telecom>
  </contact>
  <contact>
    <name value="Digital Health Agency Kenya – FHIR Team"/>
    <telecom>
      <system value="email"/>
      <value value="info@dha.go.ke"/>
      <use value="work"/>
    </telecom>
    <telecom>
      <system value="url"/>
      <value value="https://dha.go.ke"/>
      <use value="work"/>
    </telecom>
  </contact>
  <description
               value="Standard oncology chemotherapy regimen codes used in Kenya."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="KE"/>
      <display value="Kenya"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="23"/>
  <concept>
    <code value="AC"/>
    <display value="AC"/>
    <definition value="Doxorubicin + Cyclophosphamide"/>
  </concept>
  <concept>
    <code value="AC-T"/>
    <display value="AC-T"/>
    <definition
                value="Doxorubicin + Cyclophosphamide followed by Paclitaxel"/>
  </concept>
  <concept>
    <code value="AC-TH"/>
    <display value="AC-TH"/>
    <definition value="AC-T with Trastuzumab (HER2+)"/>
  </concept>
  <concept>
    <code value="CMF"/>
    <display value="CMF"/>
    <definition value="Cyclophosphamide + Methotrexate + 5-Fluorouracil"/>
  </concept>
  <concept>
    <code value="FAC"/>
    <display value="FAC"/>
    <definition value="5-Fluorouracil + Doxorubicin + Cyclophosphamide"/>
  </concept>
  <concept>
    <code value="FEC"/>
    <display value="FEC"/>
    <definition value="5-Fluorouracil + Epirubicin + Cyclophosphamide"/>
  </concept>
  <concept>
    <code value="TC"/>
    <display value="TC"/>
    <definition value="Docetaxel + Cyclophosphamide"/>
  </concept>
  <concept>
    <code value="FOLFOX"/>
    <display value="FOLFOX"/>
    <definition value="5-Fluorouracil + Leucovorin + Oxaliplatin"/>
  </concept>
  <concept>
    <code value="FOLFIRI"/>
    <display value="FOLFIRI"/>
    <definition value="5-Fluorouracil + Leucovorin + Irinotecan"/>
  </concept>
  <concept>
    <code value="CAPOX"/>
    <display value="CAPOX/XELOX"/>
    <definition value="Capecitabine + Oxaliplatin"/>
  </concept>
  <concept>
    <code value="BEP"/>
    <display value="BEP"/>
    <definition value="Bleomycin + Etoposide + Cisplatin"/>
  </concept>
  <concept>
    <code value="CHOP"/>
    <display value="CHOP"/>
    <definition
                value="Cyclophosphamide + Doxorubicin + Vincristine + Prednisone"/>
  </concept>
  <concept>
    <code value="R-CHOP"/>
    <display value="R-CHOP"/>
    <definition value="Rituximab + CHOP"/>
  </concept>
  <concept>
    <code value="ABVD"/>
    <display value="ABVD"/>
    <definition value="Doxorubicin + Bleomycin + Vinblastine + Dacarbazine"/>
  </concept>
  <concept>
    <code value="GEM-CIS"/>
    <display value="Gem-Cis"/>
    <definition value="Gemcitabine + Cisplatin"/>
  </concept>
  <concept>
    <code value="GEM-CARBO"/>
    <display value="Gem-Carbo"/>
    <definition value="Gemcitabine + Carboplatin"/>
  </concept>
  <concept>
    <code value="PACLITAXEL-CARBO"/>
    <display value="Paclitaxel-Carboplatin"/>
    <definition value="Paclitaxel + Carboplatin"/>
  </concept>
  <concept>
    <code value="CISPLATIN-5FU"/>
    <display value="Cisplatin-5FU"/>
    <definition value="Cisplatin + 5-Fluorouracil"/>
  </concept>
  <concept>
    <code value="SINGLE-CAPECITABINE"/>
    <display value="Single-agent Capecitabine"/>
    <definition value="Capecitabine monotherapy"/>
  </concept>
  <concept>
    <code value="SINGLE-PACLITAXEL"/>
    <display value="Single-agent Paclitaxel"/>
    <definition value="Paclitaxel monotherapy"/>
  </concept>
  <concept>
    <code value="SINGLE-GEMCITABINE"/>
    <display value="Single-agent Gemcitabine"/>
    <definition value="Gemcitabine monotherapy"/>
  </concept>
  <concept>
    <code value="MVAC"/>
    <display value="MVAC"/>
    <definition value="Methotrexate + Vinblastine + Doxorubicin + Cisplatin"/>
  </concept>
  <concept>
    <code value="OTHER"/>
    <display value="Other"/>
    <definition value="Regimen not listed; specify in free text."/>
  </concept>
</CodeSystem>